0.679
-0.061
(-8.24%)
May 24 - Close
NYSEMKT
real-time data -
Disclaimer
Currency in USD
| Range | 0.61 - 0.77 |
| 52 week | 0.51 - 2.00 |
| Open | 0.77 |
| Vol / Avg. | 168,206.00/133,062.00 |
| Mkt cap | 29.04M |
| P/E | - |
| Div/yield | - |
| EPS | -0.20 |
| Shares | 42.76M |
| Beta | - |
| Inst. own | 14% |
Events
May 10, 2013
Q1 2013 Bacterin International Holdings Inc Earnings Conference Call
Mar 27, 2013
Q4 2012 Bacterin International Holdings Inc Earnings Conference Call
Mar 19, 2013
Bacterin International Holdings Inc at Canaccord Genuity Musculoskeletal Conference
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | -19.37% | -23.39% |
| Operating margin | -14.31% | -14.99% |
| EBITD margin | - | -12.62% |
| Return on average assets | -19.91% | -26.75% |
| Return on average equity | -194.36% | -158.50% |
| Employees | 177 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Bacterin International Holdings, Inc. is a United States-based company, which manufactures and markets biologics products. It operates as medical device company and accredited tissue bank that designs and markets advanced medical products. The Company develops bone graft material and antimicrobial coatings for medical applications. Its biologics products include OsteoSponge, OsteoSponge SC, OsteoLock, BacFast and hMatrix dermal scaffold, In addition, the Company offers coatings for medical devices.
Officers and directors
| Kent L. Swanson | Independent Acting Chairman of the Board | |
| John P. Gandolfo | Interim Co-Chief Executive Officer, Chief Financial Officer | |
| Darrel Lee Holmes | Interim Co-Chief Executive Officer, Chief Operating Officer | |
| Nicholas Maxwell Navarro | National Sales Manager | |
| John Deedrick | Director | |
| Mitchell T. Godfrey | Director | |
| Michael A. Lopach | Independent Director | |
| Jon M. Wickwire | Independent Director |